Pertussis

Medicine (United States)

Volumn 54, Issue 6, 1975, Pages 427-469

  Olson, Lloyd C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; PERTUSSIS VACCINE;

ANIMAL; ARTICLE; BACTERIAL INFECTION; BORDETELLA; CHILD; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; PERTUSSIS; PRESCHOOL CHILD;

ANIMAL; BORDETELLA; BORDETELLA INFECTIONS; CHILD; CHILD, PRESCHOOL; ENDOTOXINS; FEMALE; HUMAN; INFANT; MALE; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 0016570357     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-197511000-00001     Document Type: Article

References (410)

1. Abayomi, I., Woodland, M. and Morley, D.: Whooping cough vaccine at birth. J. Trop. Pediatr., 19: 3, 1973.
2. Abbott, J. D., Preston, N. W. and Mackay, R. I.: Agglutinin response to pertussis vaccination in the child. Br. Med. J., 1: 86, 1971.
3. Abrahams, I.: Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J. Immunol., 96: 525, 1966.
4. Ackers, J. P. and Dolby, J. M.: The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice. J. Gen. Microbiol., 70: 371, 1972.
5. Adams, A. I.: Pertussis in Sydney: an indicator of the problem facing health educators. Med. J. Aust., 1: 41, 1966.
6. Adasek, P. J., Meyer, M. N. and Ray, C. G.: Antibiotics and their effect on Bordetella pertussis in the nasopharynx. Pediatrics, 44: 606, 1969.
7. Adcock, K. J., Reddy, S., Okubadejo, O. A. and Montefiore, D.: Trimethoprim/sulphamethox-azole in pertussis: comparison with tetracycline. Arch. Dis. Child., 47: 311, 1972.
8. Adlam, C, Broughton, E. S. and Scott, M. T.: Enhanced resistance of mice to infection with bacteria following pre-treatment with Coryne-bacterium parvum. Nature (New Biol.), 235: 219, 1972.
9. Adler, A. and Morse, S. I.: Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis. Infect. Immun., 7: 461, 1973.
10. Aftandelians, R. and Connor, J. D.: Bactericidal antibody in serum during infection with Bordetella pertussis. J. Infect. Dis., 128: 555, 1973.
11. Aftandelians, R. and Connor, J. D.: Immunologie studies of pertussis. Development of precipitins. J. Pediatr., 83: 206, 1973.
12. Alexander, J.: Mediastinal ausculation (physical signs in influenza and pertussis). N.Y. State J. Med., 58: 2796, 1958.
13. Ames, R. G., Cohen, S. M., Fischer, A. E., Kohn, J., McPherson, A. Z., Marlow, J., Rutzky, J. and Alexander H. E.: Comparison of the therapeutic efficacy of four agents in pertussis. Pediatrics, 11: 323, 1953.
14. Andersen, E. K.: Studies on reproducibility in detecting a decline in protection during immunization against H. pertussis infection, and on the effect of pertussis immunization on the resistance of mice to heterologous infection. Acta Pathol. Microbiol. Scand., 40: 235, 1957.
15. Anonymous: Treatment of whooping-cough. Br. Med. J., 2: 619, 1970.
16. Anonymous: What causes whooping cough? Lancet, 2: 917, 1970.
17. Anonymous: Pertussis in adults. Br. Med. J., 4: 316, 1972.
18. Aprile, M. A.: A reexamination of phase IV Bordetella pertussis. Can. J. Microbiol., 18: 1793, 1972.
19. Aprile, M. A. and Wardlaw, A. C: Immunochemical studies on the lipopofysaccharides of Bordetella pertussis. Can. J. Microbiol., 19: 231, 1973.
20. Arko, R. J., Kraus, S. J., Brown, W. J., Buchanan, T. M. and Kuhn, U.S.G.: Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzaees to urethral infection. J. Infect. Dis., 130: 1974.
21. Arora, S., Sanyal, R. K. and West, G. B.: The sensitizing action of Bordetella pertussis vaccine. Int. Arch. Allergy Appl. Microbiol., 37: 357, 1970.
22. Baginsky, A.: Pertussis, whooping-cough, tussisconvulsiva. Pages 773-787 in J. C. Wilson, Infectious Diseases. D. Appleton and Co., New York, 1910.
23. Baines, J. H. E.: Immunization against whooping-cough. Br. Med. J., 2: 592, 1965.
24. Balagtas, R. C, Nelson, K. E., Levin, S. and Gotoff, S. P.: Treatment of pertussis with pertussis immune globulin. J. Pediatr., 79: 203, 1971.
25. Banerjea, A. and Munoz, J.: Antigens of Bordetella pertussis. II. Purification of heat-labile toxin. J. Bacteriol., 84: 269, 1962.
26. Banker, D. D.: Modern practice in immunization. 8. Pertussis immunization. Indian J. Med. Sci., 22: 649, 1968.
27. Banks, H. S: Whooping-cough. Br. Med. J., 1: 689, 1951.
28. Barta, G.: Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate. J. Immunol., 90: 72, 1963.
29. Bartlema, H. C. and Braunius, R.: Studies on vaccination against Listeria infections. Antonie van Leeuwenhoek, 37: 261, 1971.
30. Bass, J. W., Klenk, E. L., Kotheimer, J. B., Linnemann, C. C. and Smith, M. H. D.: Antimicrobial treatment of pertussis. J. Pediatr., 75: 768, 1969.
31. Bass, J. W., Crast, F. W., Kotheimer, J. B. and Mitchell, I. A.: Susceptibility of Bordetella pertussis to nine antimicrobial agents. Am. J. Dis. Child., 117: 276, 1969.
32. Bass, J. W.: The role of antimicrobial agents in the treatment of pertussis. J. Pediatr., 83: 891, 1973.
33. Bennett, N. M.: Whooping cough in Melbourne. Med. J. Aust., 2: 481, 1973.
34. Berenbaum, M. C, Ungar, J. and Stevens, W. K.: Intracranial infection of mice with Bordetella pertussis. J. Gen. Microbiol., 22: 313, 1960.
35. Berg, J. M.: Neurological complications of pertussis immunization. Br. Med. J., 2: 24, 1958.
36. Berg, J. M.: Neurological sequelae of pertussis with particular reference to mental defect. Arch. Dis. Child., 34: 322, 1959.
37. Bergman, R. K. and Munoz, J.: Effects of epinephrine, norepinephrine and isoproteronal against histamine challenge in Bordetella pertussis-treated and β-adrenergic blocked mice. Life Sci., 10(11): 561, 1971.
38. Biering, A.: Childhood pneumonia, including pertussis pneumonia, and bronchiectasis. A follow-up study of 151 patients. Acta. Paediatr., 45: 348, 1956.
39. Billaudelle, H., Edebo, L., Hammarsten, E., Heden, G. G., Malmgren, B. and Palmstierna, H.: Studies on the chemical and immunological structure of Bordetella pertussis. Acta Pathol. Microbiol. Scand., 50: 208, 1960.
40. Binaghi, R. A. and Benacerraf, B.: The production of anaphylactic antibody in the rat. J. Immunol., 92: 920, 1964.
41. Binaghi, R. A., Benacerraf, B., Bloch, K. J. and Kourilsky, F. M.: Properties of rat anaphylactic antibody. J. Immunol., 92: 927, 1964.
42. Biro, Z.: Twelve additional cases of eosinophilic interstitial pertussoid pneumonia in infants [in German] Helv. Paediatr. Acta., 15: 135, 1960.
43. Bishop, W. B., Carlton, R. F. and Sanders. L. L.: Diffuse vasculitis and death after hyperimmunization with pertussis vaccine. N. Engl. J. Med., 274: 616, 1966.
44. Blaskett, A. C, Gulasekharam, J. and Fulton, L. C: The occurrence of Bordetella pertussis serotypes in Australia, 1950-1970. Med. J. Aust. 1: 781, 1971.
45. Blattner, R. J.: The whooping cough syndrome. J. Pediatr., 65: 150, 1964.
46. Bloomfield, A. L.: Whooping cough. Pages 529-537 in A Bibliography of Internal Medicine. Communicable disease. Univ. Chicago Press, 1958.
47. Blozis, G. C, Spargo, B. and Rowley, D. A.: Glomerular basement membrane changes with the nephrotic syndrome produced in the rat by homologous kidney and Hemophilus pertussis vaccine. Am. J. Pathol., 40: 153, 1962.
48. Bogdan, A.: The diagnosis of pertussis with supralaryngeal and modified pernasal swab. Arch. Dis. Child., 32: 450, 1957.
49. Borecky, L. and Lackovič, V.: Partial heterolo gous tolerance to interferon production in mice infected with B. pertussis. Acta Virol., 10: 271, 1966.
50. Borska, K. and Simkovicova, M.: Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J. Hyg. Epidemiol. Immunol., 16: 159, 1972.
51. Bousfield, G.: Efficacy of whooping cough vaccines. Br. Med. J., 1: 680, 1973.
52. Boyer, N. H., Adamis, D. and Weinstein, L. D.: An electrocardiographic study of uncomplicated pertussis. J. Pediatr., 49: 567, 1956.
53. Bradford, W. L.: Recent contributions to the diagnosis and treatment of pertussis. N.Y. State J. Med., 49: 397, 1949.
54. Bradford, W. L., Scherp, H. W. and Tinker, M. R.: Effect of extracts of Hemophilus pertussis on leukocyte counts in normal and sensitized mice. Pediatrics, 18: 64, 1956.
55. Bradford, W. L., Day, E. and Berry, G. P.: Improvement of the nasopharyngeal swab method of diagnosis in pertussis by the use of penicillin. Am. J. Public Health, 36: 468, 1960.
56. Bradstreet, C. M. P., Tannahill, A. J. and Edwards, J. M. B.: Detection of Bordetella pertussis antibodies in human sera by complement-fixation and immunofluorescence. J. Hyg. (Camb.), 70: 75, 1972.
57. Branefors, P.: Transformation of streptomycinresistance in Bordetella pertussis. Acta Pathol. Microbiol. Scand., 62: 249, 1964.
58. Brent, L. and Pinto, M.: Induction of specific unresponsiveness with the aid of Bordetella pertussis. Transplant. Proc, V: 697, 1973.
59. Brighton, W. D., Lampard, J., Sheffield, F. and Perkins, F. T.: Variation of killing power of human sera against Bordetella pertussis. Clin. Exp. Immunol., 5: 541, 1969.
60. Brooks, G. F. and Buchanan, T. M.: Pertussis in the United States. J. Infect. Dis., 122: 123, 1970.
61. Brooksaler, F. and Nelson, J. D.: Pertussis. A reappraisal and report of 190 confirmed cases. Am. J. Dis. Child., 114: 389, 1967.
62. Brooksaler, F. S.: The pertussis syndrome. Tex. Med., 67: 56, 1971.
63. Brown, A. M.: Growth idiosyncracies of some Bordetella pertussis strains, and the intracerebral virulence of these strains in mice. J. Gen. Microbiol., 20: 532, 1959.
64. Brown, G. C: Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current status of combined vaccines. Health Lab. Sci., 8: 210, 1971.
65. Brown, J. H.: Bacillus bronchiseptica infection in child with symptoms of pertussis. Bull. Johns Hopkins Hosp., 38: 147, 1926.
66. Buck, C: A note on trends in pertussis mortality and morbidity in Ontario. Can. J. Public Health, 52: 352, 1961.
67. Buescher, E. L.: Respiratory disease and the adenoviruses. Med. Clin. North Am., 51: 769, 1967.
68. Burianová-Vysoká, B., Burian, V., Křiž, B., Pellar, T., Hellerová, J. and Radkovský, J.: Experiences with a new combined vaccine against B. parapertussis, diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10. Prog. Immunobiol. Stand., 3: 335, 1969.
69. Butler, N. R, Wilson, B. D. R, Benson, P. F., Dudgeon, J. A., Ungar, J. and Beale, A. J.: Response of infants to pertussis at one week and to poliomyelitis, diphtheria, and tetanus vaccine at six months. Lancet, 2: 112, 1962.
70. Bwibo, N. O.: Whooping cough in Uganda. Scand. J. Infect. Dis., 3: 41, 1971.
71. Byers, R. K. and Moll, F. C: Encephalopathies following prophylactic pertussis vaccine. Pediatrics, 1: 437, 1948.
72. Byers, R. K. and Rizzo, N. D.: A follow-up study of pertussis in infancy. N. Engl. J. Med., 242: 887, 1950.
73. Cameron, J.: Variation in Bordetella pertussis. J. Path. Bacteriol., 94: 367, 1967.
74. Cameron, J.: The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines. Prog. Immunobiol. Stand., 3: 302, 1969.
75. Celermajer, J. M. and Brown, J.: The neurological complications of pertussis. Med. J. Aust., 1: 1066, 1966.
76. Center for Disease Control Diphtheria and tetanus toxoids and pertussis vaccine. Ann. Intern. Med., 76: 289, 1972.
77. Diphtheria and tetanus toxoids and pertussis vaccine. Center for Disease Control. Diphtheria and tetanus toxoids and pertussis vaccine. Recommendations of the Public Health Service Advisory Committee on Immunization Practices. Ann. Intern. Med., 76: 289, 1972.
78. Chakravorty, A. P.: Blindness after use of triple antigen. Br. Med. J., 1: 105, 1963.
79. Chalvardijian, N.: The content of antigens 1, 2 and 3 in strains of Bordetella pertussis and in vaccines. Can. Med. Assoc. J., 92: 1114, 1965.
80. Chalvardijian, N.: The laboratory diagnosis of whooping cough by fluorescent antibody and by culture methods. Can. Med. Assoc. J., 95: 263, 1966.
81. Chang, I. C. and Gottshall, R. Y.: Sensitization of mice by inhalation of antigen after infection with Bordetella pertussis. Infect. Immun., 6: 92, 1972.
82. Chany, C, Lépine, P. Lelong, M., Le-Tan-Vinh, Satgé, P. and Virat, J.: Severe and fatal pneumonia in infants and young children associated with adenovirus infections. Am. J. Hyg., 67: 367, 1958.
83. Cheers, C: Delayed hypersensitivity in murine pulmonary pertussis. Aust. J. Exp. Biol. Med. Sci., 47: 513, 1969.
84. Cheers, C. and Gray, D. F.: Macrophage behaviour during the complaisant phase of murine pertussis. Immunology, 17: 875, 1969.
85. Chireshkina, N. M., Makarova, V. A. and Dreizin, R. S.: On the problem of the pathogenic role of adenoviruses in patients with whooping cough and measles [in Russian]. Pediatriia, 40: 34, 1961.
86. Choremis, C. B., Megas, H. A. and Askouni, A. D.: Bone marrow studies in patients suffering from infections and receiving chloramphenicol. Acta Paediatr., 52: 136, 1963.
87. Christie, A. B.: Infectious Diseases: Epidemiology and Clinical Practise. E. and S. Livingstone, Ltd., London, 1969.
88. Christensen, C. N.: More risky to give or not to give? Am. J. Dis. Child., 105: 417, 1963.
89. Clausen, C, Munoz, J. and Bergman, R. K.: Lymphocytosis and histamine sensitization of mice by fractions from Bordetella pertussis. J. Bacteriol., 96: 1484, 1968.
90. Clausen, C. R., Munoz, J. and Bergman, R. K.: Reaginic-type of antibody in mice stimulated by extracts of Bordetella pertussis. J. Immunol., 103: 768, 1969.
91. Clausen, C. R., Munoz, J. and Bergman, R. K.: A reaginic type of antibody stimulated by extracts of Bordetella pertussis in inbred strains of mice. J. Immunol., 104: 312, 1970.
92. Clinical-Pathologic Conference, Willard Parker Hospital. Pertussis encephalopathy. Arch. Pediatr., 66: 44, 1949.
93. Cohen, R.: A laboratory diagnostic sign for pertussis. Arch. Pediatr., 71: 151, 1954.
94. Cohen, S. G.: The eosinophil and eosinophilia. N. Engl. J. Med., 290: 457, 1974.
95. Cohen, S. G., Sapp, T. M. and Chiampi, P. N.: Eosinophil leukocyte responses and hypersensitivity reactions in the Bordetella pertussis-treated mouse. J. Allergy, 46: 205, 1970.
96. Collier, A. M., Connor, J. D. and Irving, W. R., Jr.: Generalized type 5 adenovirus infections associated with the pertussis syndrome. J. Pediatr, 69: 1073, 1966.
97. Combined Scottish Study. Diagnosis of whooping cough: comparison of serological tests with the isolation of Bordetella pertussis. Br. Med. J., 4: 637, 1970.
98. Committee on Infectious Diseases. Report, 17th edition. American Academy of Pediatrics, Evanston, Illinois, 1974.
99. Cone, T. E., Jr.: Whooping cough is first described as a disease sui generis by Baillou in 1640. Pediatrics, 46: 522, 1970.
100. Connor, J. D.: Evidence for an etiologic role of adenoviral infection in pertussis syndrome. N. Engl. J. Med., 283: 390, 1970.
101. Connor, J. D.: Correspondence. N. Engl. J. Med., 283: 1174, 1970.
102. Cooney, D., Eckhardt, S. and Goldin, A.: Response of leukemoid reaction induced by Bordetella pertussis vaccine to chemotherapeutic agents. Antimicrob. Agents Chemother., 5: 509, 1965.
103. Court, D., Jackson, H. and Knox, G.: The recognition of whooping cough. Lancet, 2: 1057, 1953.
104. Crawford, J. G. and Fishel, C. W.: Growth of Bordetella pertussis in tissue culture. J. Bacteriol. 77: 465, 1959.
105. Dachy, A.: Viral infections as a cause of the pertussis syndrome. Preliminary observations [in French]. Acta. Paediatr. Belg., 22: 113, 1968.
106. Davis, B. D., Dulbecco, R., Eisen, H. N., Ginsberg, H., and Wood, W. B., Jr.: Microbiology, 2nd edition. Hoeber Medical Division, N.Y., 1973, pp. 632.
107. Dayal, R. S., Atal, P. R. and Kumar, Y.: A comparative study of different culture techniques and therapeutic efficacy of newer antibiotics in pertussis. Indian J. Med. Sci., 23: 421, 1969.
108. Dean, D. J., Cohen, S. M. and Dalldorf, G.: The effect of unrelated vaccines on the localization of paralysis in mouse encephalomyelitis. Proc. Soc. Exp. Biol. Med., 77: 834, 1951.
109. Demina, A. A., Devyatkina, N. P., Voloshina, L. Z., Larina, L. L, Semina, N.A., Venglinskaya, E.A. and Kostyukova, K.P: Serological types of whooping cough bacteria and their connection with immunity in vaccinated children. J. Hyg. Epidemiol. Microbiol. Immunol., 17: 304, 1973.
110. Dolby, J. M.: The antibacterial effect of Bordetella pertussis antisera. Immunology, 8: 484, 1965.
111. Dolby, J. M. Passive protection of mice against intracerebral infections with Bordetella pertussis. J. Hyg. (Camb.), 70: 707, 1972.
112. Dolby, J. M. and Standfast, A.F.B.: A comparison of passive protection tests against intranasal and intracerebral challenges with Bordetella pertussis. Immunology, 1: 144, 1958.
113. Dolby, J. M. and Vincent, W.A.: Characterization of the antibodies responsible for the 'bactericidal activity patterns' of antisera to Bordetella pertussis. Immunology, 8: 499, 1965.
114. Dolby, J. M. and Stephens, S.: Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J. Hyg. (Camb.), 71: 193, 1973.
115. Dolby, J. M. and Dolby, D. E.: The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis. Immunology, 16: 737, 1969.
116. Donaldson, P. and Whitaker, J.A.: Diagnosis of pertussis by fluorescent antibody staining of nasopharyngeal smears. Am. J. Dis. Child., 99: 423, 1960.
117. Donchev, D. and Stoyanova, M.: The epidemiological significance of the differentiation of pertussis and parapertussis. J. Hyg. Epidemiol. Microbiol. Immunol., 5: 294, 1961.
118. Dubos, R. J. and Schaedler, R. W.: Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J. Exp. Med., 104; 53, 1956.
119. Duncan, J. R., Ramsey, F. K. and Switzer, W. P.: Pathology of experimental Bordetella bronchiseptica infection in swine: pneumonia. Am. J. Vet. Res. 27: 467, 1966.
120. Editorial. Pertussis. J.A.M.A., 202: 209, 1967.
121. Eikman, E. A. and Bowser, R. T.: Alteration in graft vs host reactivity and in hematopoietic stem cells of spleen cell inocula from donor mice pretreated with pertussis antigen. J. Immunol., 108: 253, 1972.
122. Eidering, G.: Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: historical notes on pertussis immunization. Health Lab. Sci., 8: 200, 1971.
123. Eidering, G. and Kendrick, P. L.: Incidence of parapertussis in the Grand Rapids area as indicated by 16 years' experience with diagnostic cultures. Am. J. Public Health, 42: 27, 1952.
124. Eldering, G., Hornbeck, C. and Baker, J.: Serological study of Bordetella pertussis and related species. J. Bacteriol., 74: 133, 1957.
125. Eldering, G., Eveland, W. C. and Kendrick, P. L.: Fluorescent antibody staining and agglutination reactions in Bordetella pertussis cultures. J. Bacteriol., 83: 745, 1962.
126. Eldering, G., Holwerda, J. and Baker, J.: Bordetella pertussis culture having only species factor 1. J. Bacteriol., 91: 1759, 1966.
127. Eldering, G., Holwerda, J. and Baker, J.: Mouse-protective properties of Bordetella pertussis serotypes in passive tests. J. Bacteriol., 93: 1758, 1967.
128. Eldering, G., Holwerda, J., Davis, A. and Baker, J.: Bordetella pertussis serotypes in the United States. Appl. Microbiol., 18: 618, 1969.
129. Ernström, U. and Larsson, B.: Changes in circulating populations in pertussis-vaccinated guinea pigs. Acta Pathol. Microbiol. Scand. 69: 595, 1967.
130. Etheridge, J. E., Jr. and Millichap, J. G.: Hypoglycemia and seizures in childhood. Neurology, 14: 397, 1964.
131. Evans, D. G. and Adams, M. O.: The inability of the capsular material of Haemophilus pertussis to produce protective antisera. J. Gen. Microbiol., 7: 169, 1952.
132. Farber, S. and Vawter, G. F.: Clinical pathological conference. J. Pediatr., 58: 876, 1961.
133. Farthing, J. R.: The role of Bordetella pertussis as an adjuvant to antibody production. Br. J. Exp. Pathol., 42: 614, 1961.
134. Farthing, J. R. and Holt, L. B.: Experiments designed to determine the mechansim of the adjuvant activity of Gram-negative organisms upon antibody production. J. Hyg. (Camb.), 60: 411, 1962.
135. Fauve, R. M. and Hevin, M. B.: Influence of corticosteroids, endotoxin, Corynebacterium parvum and polyinosinic, polycytidilic (Poly: I.C.) on the bactericidal power of spleen and liver macrophages from the mouse. Ann. Inst. Pasteur, 120: 399, 1971.
136. Fawcitt, J. and Parry, H. E.: Lung changes in pertussis and measles in childhood. A review of 1894 cases with a follow-up study of the pulmonary complications. Br. J. Radiol., 30: 76, 1957.
137. Felton, H. M.: Pertussis. Current status of prevention and treatment. Pediatr. Clin. North Am., Feb., 1957, pp. 271-283.
138. Felton, H. M., Gaggero, A. and Pomerat, C. M.: Reactions of cells in tissue culture to Hemophilus pertussis. I. Effect of whole organisms on brain tissue and results of treatment with specific and normal serum. Tex. Rep. Biol. Med., 12: 960, 1954.
139. Finger, H.: Possible mechanism of adjuvant action. Int. Arch. Allergy Appl. Microbiol., 36(Suppl.): 293, 1969.
140. Finger, H., Bmmerling, P. and Plager, L.: Hematopoietic changes in NMRI mice after the intravenous and subcutaneous injection of Bordetella pertussis vaccine. Experientia, 28: 1484, 1972.
141. Finger, H., Folmer, L, Plager, L. and Henseling, M.: Overcoming of endotoxin-mediated immunosuppression by Bordetella pertussis. Experientia, 28: 562, 1972.
142. Finstead, J.: Markers of lymphoid cells in primitive vertebrates. Fed. Proc, 25: 534, 1966.
143. Fishel, C. W.: Host-parasite relationship in experimental pertussis. I. Histamine-sensitizing and protective activities of pertussis vaccine in mice. J. Infect. Dis., 99: 44, 1956.
144. Fishel, C. W. and Szentivanyi, A.: The absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice and its relation to histamine and serotonin hypersensitivity. J. Allergy, 34: 439, 1963.
145. Floersheim, G. L.: Effect of pertussis vaccine on the tuberculin reaction. Int. Arch. Allergy Appl. Microbiol., 26: 340, 1965.
146. Floersheim, G. L.: Further studies pertaining to a B. pertussis factor inhibiting the tuberculin reaction. Experientia, 22: 219, 1966.
147. Friedman, I., Ron, N., Laufer, A. and Davies, A. M.: Experimental myocarditis: enhancement by the use of pertussis vaccine in Lewis rats. Experientia, 26: 1143, 1970.
148. Gajdusek, D. C: Slow virus diseases of the central nervous system. Am. J. Clin. Pathol., 56: 320, 1971.
149. Geffen, D., Paterson, J. H. and Tracy, S.M.: Poliomyelitis following inoculation. A survey of 29 children. Lancet, 1: 1268, 1953.
150. Geller, B. D. and Pittman, M.: Immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis. Infect. Immun., 8: 83, 1973.
151. Gibbs, E. L., Gibbs, F. A. and Grossman, H.: Electroencephalographic evidence of encephalitis in children with supposedly uncomplicated childhood diseases. Trans. Am. Neurol. Assoc, 1956, pp. 159-160.
152. Goldner, M., Jakus, C. M., Rhodes, H. K. and Wilson, R. J.: The amino acid utilization by phase I Bordetella pertussis in a chemically defined medium. J. Gen. Microbiol., 44: 439, 1966.
153. Goodpasture, E. W., Auerbach, S. H., Swanson, H. S. and Cotter, E. F. Virus pneumonia of infants secondary to epidemic infections. Am. J. Dis. Child., 57: 997, 1939.
154. Gordon, J. E. and Hood, R. I.: Whooping cough and its epidemiological anomalies. Am. J. Med. Sci., 222: 333, 1951.
155. Gözsy, B. and Kátó, L.: Sensitizing properties of B. pertussis in the mouse and rat. Rev. Can. Biol., 23: 427, 1964.
156. Gray, D. F. and Cheers, C: The steady state in cellular immunity. II. Immunological com plaisance in murine pertussis. Aust. J. Exp. Biol. Med., 45: 417, 1967.
157. Gray, D. F. and Cheers, C: The sequence of enhanced cellular activity and protective humoral factors in murine pertussis immunity. Immunology, 17: 889, 1969.
158. Graydon, J. J.: Whooping-cough vaccination. Med. J. Aust., 2: 251, 1964.
159. Gruenwald, R., Allen, E. G., Levine, S. and Wenk, E. J.: Studies on mechanism of ascites produced by pertussis vaccine. Proc. Soc. Exp. Biol. Med., 108: 109, 1961.
160. Gulbenkian, A., Schobert, L., Nixon, C. and Tabachnick, I. I. A.: Metabolic effects of pertussis sensitization in mice and rats. Endocrinology, 83: 885, 1968.
161. Hargis, B. J., Malkiel, S. and Berkelhammer, J.: Immunologically induced aspermatogenesis in the white mouse. J. Immunol., 101: 374, 1968.
162. Hasenclaver, H. F. and Corley, E. J.: Enhancement of acquired resistance in murine Can-didiasis by Bordetella pertussis vaccine. Sa-bouraudia, 6: 289, 1968.
163. Heilig, W. R.: Encephalopathies following DPT inoculations and pertussis. Minn. Med., 40: 542, 1957.
164. Hellström, B.: Electroencephalographics studies in triple-immunized infants. Br. Med. J., 2: 1089, 1962.
165. Hirano, M., Sinkovics, J. G., Shullenberger, C. C. and Howe, C. D.: Murine lymphoma: augmented growth in mice with pertussis vaccine-induced lymphocytosis. Science, 158: 1061, 1967.
166. Holt, L. B.: A re-assessment of the risk of provoking paralytic poliomyelitis by making prophylactic inoculations against diphtheria and pertussis. J. Hyg. (Camb.), 57: 150, 1959.
167. Holt, L. B.: The pathology and immunology of Bordetella pertussis infection. J. Med. Microbiol., 5: 407, 1972.
168. Holt, M. F.: Whooping-cough in general practice. Practitioner, 180: 350, 1958.
169. Holwerda, J.: Symposium on pertussis immunization in honor of Dr. Pearl Kendrick in her eightieth year: current diagnostic procedures in whooping cough. Health Lab. Sci., 8: 206, 1971.
170. Holwerda, J. and Eidering, G.: Culture and fluorescent-antibody methods in diagnosis of whooping cough. J. Bacteriol., 86: 449, 1963.
171. Homma, R. Kuratsuka, K., Shimazaki, Y. and Funasaka, I.: Purification and properties of heat-labile toxin of Bordetella pertussis. Jap. J. Med. Sci., 23: 277, 1970.
172. Hopewell, J. W. and Adams, G. A.: Modification of subsequent intracerebral infection with Bordetella pertussis by previous local brain irradiation. Exp. Neurol., 26: 173, 1970.
173. Hopewell, J. W., Holt, L. B. and Desombre, T. R.: An electron-microscopic study of intracerebral infection of mice with low-virulence Bordetella pertussis. J. Med. Microbiol., 5: 154, 1972.
174. Horner, F. A.: Second attack of pertussis. N. Engl. J. Med., 266: 470, 1962.
175. Huang, C. C, Chen, P. M., Kuo, J. K., Chiu, W. H., Lin, S. T., Lin, H. S. and Lin, Y. C: Experimental whooping cough. N. Engl. J. Med., 266: 105, 1962.
176. Huebner, R. J., Rowe, W. P., Ward, T. G., Parrott, R. H. and Bell, J. A.: Adenoidal-pharyngeal-conjunctival agents. A newly recognized group of common viruses of the respiratory system. N. Engl. J. Med., 251: 1077, 1954.
177. Iida, T., Kunitani, A., Komase, Y. and Yamamoto, A.: Studies on experimental infection with Bordetella pertussis. Effect of cortisone on the infection and immunity in mice. Jap. J. Exp. Med., 33: 283, 1963.
178. Iida, T., Kusano, N., Yamamoto, A. and Konosu, M.: An immunofluorescence study of the action of antibody in experimental intracerebral infection of mice with Bordetella pertussis. J. Path. Bacteriol., 92: 359, 1966.
179. Iida, T. and Okonogi, T.: Lienotoxicity of Bordetella pertussis in mice. J. Med. Microbiol., 4: 51, 1971.
180. Iida, T. and Tajima, M.: Stimulation of nonspecific resistance by heterologous endotoxins and experimental immunity to Bordetella pertussis in mice. Immunology, 21: 313, 1971.
181. Iwasa, S. Yoshikawa, T., Fukumura, K. and Kurokawa, M.: Effects of the lymphocytosis-promoting factor from Bordetella pertussis on the function and potentiality of lymphocytes. I. Effects on the ability of lymphocytes to recirculate in the body. Jap. J. Med. Sci. Biol., 23: 47, 1970.
182. Jackson, F. E.: Spontaneous spinal epidural hematoma coincident with whooping cough. J. Neurosurg., 20: 715, 1963.
183. Jaffe, V. R: Incidence of pertussis in vaccinated and unvaccinated children. Report of 100 cases followed in a child health clinic. J. Pediatr., 47: 716, 1955.
184. Jamieson, W. M.: Whooping cough. Br. Med. J., 5: 223, 1973.
185. Jebb, W. H. H. and Tomlinson, A. H.: The minimal amino acid requirements of Haemophilus pertussis. J. Gen. Microbiol., 17: 59, 1957.
186. Jernelius, H.: Tetracycline treatment of whooping cough. Acta Paediatr., 45: 516, 1956.
187. Jernelius, H.: Pertussis with pulmonary complications-a follow up study. Acta Paediatr., 53: 247, 1964.
188. Jones, G. L. and Kendrick, P. L.: Study of a blood-free medium for transport and growth of Bordetella pertussis. Health Lab. Sci., 6: 40, 1969.
189. Joseph, R., Lepine, P., Maurin, J., Job, J. C. and Chany, C: Simultaneous infection by Hemophilus pertussis and by a type 5 adenovirus in a young girl with whooping cough and cerebral complications [in French]. Presse Med., 66: 1550, 1958.
190. Kalden, J. R., Williamson, W. G. and Irvine, W. J.: The effect of Bordetella pertussis vaccine on the development of experimental thyroidi-tis in rats immunized by the intra-lymph node or into a hind footpad. Clin. Exp. Immunol., 5: 549, 1969.
191. Kalpaktsoglou, P. A., Yunis, E. J. and Good, R. J.: Changes produced by pertussis antigen on the blood cells and lympho-haemopoietic tissues after early and late thymectomy or splenectomy. Clin. Exp. Immunol., 5: 91, 1969.
192. Kalpaktsoglou, P. K. and Good, R. A.: Effect of pertussis antigen and cyclophosphamide on myeloma tumor. Cancer Res., 30: 2841, 1970.
193. Kasuga, T., Nakase, Y., Ukishima, K. and Takatsu, K.: Studies on Haemophilus pertussis. Part I. Antigen structure of H. pertussis and its phase. Kitasato Arch. Exp. Med., 26: 121, 1953.
194. Kasuga, T., Nakase, Y., Ukishima, K. and Takatsu, K.: Studies on Haemophilus pertussis. Part V. Relation between the phase of bacilli and the progress of the whooping-cough. Kitasato Arch. Exp. Med., 27: 57, 1954.
195. Kasuga, T. and Nakase, Y.: Serological relationship between H. pertussis, H. parapertussis and H. bronchisepticus. Jap. J. Microbiol., 4: 283, 1960.
196. Kaufman, S. and Bruyn, H. G.: Pertussis. A clinical study. Am. J. Dis. Child., 99: 417, 1960.
197. Kay, A. B.: The eosinophil in infectious disease. J. Infect. Dis., 129: 606, 1974.
198. Kendrick, P. L.: Secondary familial attack rates from pertussis in vaccinated and unvaccinated children. Am. J. Hyg., 32: 89, 1940.
199. Kendrick, P. L.: Occasional sporadic cases of whooping cough-like syndrome associated with adenoviral infection: contrast with epidemic whooping cough caused by Bordetella pertussis. Health Lab. Sci., 8: 194, 1971.
200. Kenrick, P. L., Eldering, G. and Eveland, W. C: Fluorescent antibody techniques. Methods for identification of Bordetella pertussis. Am. J. Dis. Child., 101: 149, 1961.
201. Kendrick, P. L., Gottshall, R. Y., Anderson, H.D., Volk, V. K., Bunney, W. E. and Top, F. H.: Pertussis agglutinins in adults. Public Health Rep., 84: 9, 1969.
202. Kesson, C. W. and Harling, M.: An investigation into certain aspects of pertussis. Arch. Dis. Child., 28: 409, 1953.
203. Kind, L. S.: The altered reactivity of mice after inoculation with Bordetella pertussis vaccine. Bacteriol. Rev., 22: 173, 1958.
204. Kind, L. S. and Roesner, L.: Enhanced susceptibility of pertussis inoculated mice to pollen extract. Proc. Soc. Exp. Biol. Med., 100: 808, 1959.
205. Kind, L. S. and Richards, W. W.: Local and systemic anaphylaxis in the pertussis-inoculated mouse. Nature, 202: 309, 1964.
206. Klenk, E. L., Gaultney, J. V. and Bass, J. W.: Bacteriologically proved pertussis and adenovirus infection. Am. J. Dis. Child., 124: 203, 1972.
207. Klimt, F.: Hematology of whooping cough. A study of 319 hospitalized patients [in German]. Z. Kinderheilkd., 85: 423, 1961.
208. Kojima, Y., Yoshida, F. and Nakase, Y.: Interferon production by Bordetella pertussis components in rabbits and in rabbit cell cultures. Jap. J. Microbiol., 17: 160, 1973.
209. Kreutner, W., Gulbenkian, A. and Tabachnik, I. I. A.: Effect of epinephrine on hepatic gly-cogen phosphorylase and synthetase activities in normal and pertussis-sensitized rats. Biochem. Pharmacol., 19: 2561, 1970.
210. Kristensen, K. H. and Lautrop, H.: A family epidemic caused by the whooping-cough bacterium Bordetella bronchiseptica (in Danish). Ugeskr. Laeger, 124: 303, 1962.
211. Krugman, S. and Ward, R.: Infectious Diseases of Children and Adults, 5th edition. C. V. Mosby, St. Louis, 1973, pp. 173-181.
212. Kurokawa, M., Ishida, S. and Asakawa, S.: Attempts at analysis of toxicity of pertussis vaccine. II. Quantitative determinations of the heat-labile toxin by skin reaction. Jap. J. Med. Sci. Biol., 22: 293, 1969.
213. Kurt, T. L., Yeager, A. S., Guenette, S. and Dunlop, S.: Spread of pertussis by hospital staff. J.A.M.A., 221: 264, 1972.
214. Kuwajima, Y., Matsui, T. and Kishigami, M.: The growth-supporting effect of some anion exchange resins for phase I Haemophilus pertussis. J. Hyg. Epidemiol. Microbiol. Immunol., 2: 16, 1958.
215. Lacey, B. W.: Antigenic modulation of Bordetella pertussis. J. Hyg. (Camb.) 58: 57, 1960.
216. Lagergren, J.: The white blood cell count and the erythrocyte sedimentation rate in pertussis. Acta. Paediatr., 52: 405, 1963.
217. Lambert, H. J.: Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep., 80: 365, 1965.
218. Lane, A. G: Appearance of mouse-lethal toxin in liquid cultures of Bordetella pertussis. Appl. Microbiol., 16: 1400, 1968.
219. Lane, A. G.: Use of glutamic acid to supplement fluid medium for cultivation of Bordetella pertussis. Appl. Microbiol., 19: 512, 1970.
220. Lang, W. R., Howden, C. W. and Costello, J. M.: Respiratory disease associated with parainfluenza and respiratory syncytial viruses. N. Z. Med. J., 63: 508, 1964.
221. Lapin, J. H.: Whooping Cough. Charles C Thomas, Springfield, Illinois, 1943.
222. Lascari, A. D.: The erythrocyte sedimentation rate. Pediatr. Clin. North Am., 19: 1113, 1972.
223. Laurance, B. M.: Chronic pulmonary infection in childhood. Practitioner, 195: 749, 1965.
224. Lautrop, H.: Observations on parapertussis in Denmark, 1950-1957. Acta Path. Microbiol. Scand., 43: 255, 1958.
225. Lautrop, H.: Laboratory diagnosis of whoopingcough or Bordetella infections. Bull. WHO, 23: 15, 1960.
226. Lautrop, H.: Epidemics of parapertussis. 20 years' observations in Denmark. Lancet, 1: 1196, 1971.
227. Lees, A. W.: Atelectasis and bronchiectasis in pertussis. Br. Med. J., 2: 1138, 1950.
228. Lenz, W. R. and Top, F. H., Sr.: Pertussis. Pages 410-417 in F. H. Top, Sr., ed. Communicable and Infectious Diseases, Sixth edition. C. V. Mosby, St. Louis, 1968.
229. Leslie, P. H. and Gardner, A. D.: The phases of Haemophilus pertussis. J. Hyg. (Camb.), 31: 423, 1931.
230. Levine, S., Wenk, E. J., Devlin, H. B., Pieroni, R. E. and Levine, L.: Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts. J. Immunol., 97: 363, 1966.
231. Levine, S. and Wenk, E. J.: Hyperacute allergic encephalomyelitis. Lymphatic system a site of adjuvant effect of pertussis vaccine. Am. J. Pathol., 50: 465, 1967.
232. Levine, S. and Iwahara, M.: Graft-versus-host disease produced with whole blood. Enhancement by pertussis vaccination of donors. Transplantation, 8: 462, 1969.
233. Levine, S. and Sowinski, R.: Inhibition of macrophage response to brain injury. A new effect of pertussis vaccine possibly related to histamine-sensitizing factor. Am. J. Pathol., 67: 349, 1972.
234. Levine, S. and Sowinski, R.: Hyperacute allergic encephalomyelitis. A localized form produced by passive transfer and pertussis vaccine. Am. J. Pathol., 73: 247, 1973.
235. Lewis, F. A., Gust, I. D. and Bennett, M. McK.: On the aetiology of whooping cough. J. Hyg. (Camb.), 71: 139, 1973.
236. Linnemann, C. C, Jr., Bass, J. W. and Smith, M. H. D.: The carrier state in pertussis. Am. J. Epidemiol., 88: 422, 1968.
237. Litkenhous, C. and Liu, P. V.: Bacteriocin produced by Bordetella pertussis. J. Bacteriol., 93: 1484, 1967.
238. Logan, J. E., Griffiths, B. W. and Mason, M. A.: Specificity of the clearance phenomenon in the lungs of pertussis-immunized mice following intratracheal administration of radioiodinated vaccine. Can. J. Microbiol., 5: 405, 1959.
239. Love, W. C, McKenzie, P., Chaudhuri, A. K. R. and Gordan, A.: What causes whooping cough? Lancet, 2: 1142, 1970.
240. McCloskey, B. P.: Residual paralysis after poliomyelitis following recent inoculation. Lancet, 1: 1187, 1952.
241. McCordock, H. A.: Intranuclear inclusions in pertussis. Proc. Soc. Exper. Biol. Med., 29: 1288, 1932.
242. McCordock, H. A. and Smith, M. G.: Intranuclear inclusions. Incidence and possible significance in whooping cough and in a variety of other conditions. Am. J. Dis. Child., 47: 111, 1934.
243. McDonald, F. C: Whooping cough with particular reference to prophylaxis and treatment with vaccines. N. Engl. J. Med., 213: 198, 1935.
244. Macdonald, H. and Macdonald, E. J.: Experimental pertussis. J. Infect. Dis., 53: 328, 1933.
245. Mackaness, G. B. and Blanden, R. V.: Cellular immunity. Prog. Allergy 11: 89, 1967.
246. Maclennan, A. P.: Specific lipopolysaccharides of Bordetella. Biochem. J., 74: 398, 1960.
247. Malkiel, S. and Hargis, B. J.: Influence of B. pertussis on host survival following S-180 implantation. Cancer Res., 21: 1461, 1961.
248. Malkiel, S. and Hargis, B. J.: Anaphylactic reactions in mice induced by Bordetella pertussis lipopolysaccharide. J. Allergy, 35: 306, 1964.
249. Malkiel, S. and Hargis, B. J.: Sensitization of the mouse to bradykinin. Proc. Soc. Exp. Biol. Med., 125: 565, 1967.
250. Malmgren, B., Vahlquist, B. and Zetterström, R.: Complications of immunization. Br. Med. J., 2: 1800, 1960.
251. Martin, G. I. and Weintraub, M. I.: Brachial neuritis and seventh nerve palsy-a rare hazard of DPT vaccination. Clin. Pediatr., 12: 506, 1973.
252. Martin, J. K.: Local paralysis in children after injections. Arch. Dis. Child., 25: 1, 1950.
253. Mason, M. A.: The spheroplasts of Bordetella pertussis. Can. J. Microbiol., 12: 539, 1966.
254. Medical Research Council. Treatment of whooping cough with antibiotics. Lancet, 1: 1109, 1953.
255. Melbin, T. and Vahlquist, B.: The antibody pattern in representative groups of Ethiopian village children: Acta Paediatr. Scand., 57: 385, 1968.
256. Milner, K. C, Anacker, R. L., Fukushi, K., Haskins, W. T., Landy, M., Malmgren, B. and Ribi, E.: Symposium on relationship of structure of microorganisms to their immunological properties. III. Structure and biological properties of surface antigens from gram-negative bacteria. Bacteriol. Rev., 27: 352, 1963.
257. Monette, F. C, Morse, B. S., Howard, D., Niskanen, E. and Stohlman, F.: Hemopoietic stem cell proliferation and migration following Bordetella pertussis vaccine. Cell Tissue Kinet., 5: 121, 1972.
258. Monto, A. S. and Cavallaro, J.J.: The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969. Am. J. Epidemiol., 94: 280, 1971.
259. Morris, D. and McDonald, J. C: Failure of hyperimmune gamma globulin to prevent whooping cough. Arch. Dis. Child., 32: 236, 1957.
260. Morse, S. I.: Studies on the lymphocytosis induced in mice by Bordetella pertussis. J. Exp. Med., 121: 49, 1965.
261. Morse, S. I. The effect of hydrocortisone and x-irradiation on the lymphocytosis induced by Bordetella pertussis. J. Exp. Med., 123: 283, 1966.
262. Morse, S. I.: Pertussis in adults. Ann. Intern. Med., 68: 953, 1968.
263. Morse, S. I.: The hemophilus-bordetella group. Pages 791-800, in Davis, et al., eds. Microbiology, 2nd edition. Hoeber Medical Division, N.Y., 1973.
264. Morse, S. I. and Riester, S. K.: Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. I. Radioautographic analysis of the circulating cells in mice undergoing pertussis-induced hyperleukocytosis. J. Exp. Med., 125: 401, 1967.
265. Morse, S. I. and Riester, S. K.: Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice. J. Exp. Med., 125: 619, 1967.
266. Morse, S. I. and Bray, K. K.: The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures. J. Exp. Med., 129: 523, 1969.
267. Morse, J. H. and Morse, S. I.: Studies on the ultrastructure of Bordetella pertussis. I. Morphology, origin, and biological activity of structures present in the extracellular fluid of liquid cultures of Bordetella pertussis. J. Exp. Med., 131: 1342, 1970.
268. Morse, S. I. and Barron, B. A.: Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. III. The distribution of transfused lymphocytes in pertussis-treated and normal mice. J. Exp. Med., 132: 663, 1970.
269. Mota, I.: Failure of rat and rabbit antiserum to passively sensitize normal and pertussis-treated rats and mice so as to induce mast cell damage and histamine release on later contact with antigen. Immunology, 5: 11, 1962.
270. Munoz, J.: Comparison of Bordetella pertussis cells and Freund's adjuvant with respect to their antibody inducing and anaphylactogenic properties. J. Immunol., 90: 132, 1963.
271. Munoz, J.: Symposium on relationship of structure of microorganisms to their immunological properties. I. Immunological and other biological activities of Bordetella pertussis antigens. Bacteriol. Rev., 27: 325, 1963.
272. Munoz, J., Ribi, E. and Larson, C. L.: Antigens of Bordetella pertussis. I. Activities of cell wall and protoplasm. J. Immunol., 83: 496, 1959.
273. Munoz, J. and Bergman, R. K.: Some histamine sensitizing properties of soluble preparations of the histamine sensitizing factor (HSF) from Bordetella pertussis. J. Immunol., 97: 120, 1966.
274. Munoz, J. and Bergman, R. K.: Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis. Bacteriol. Rev., 32: 103, 1968.
275. Nakase, Y., Takatsu, K., Tateishi, M., Sekiya, K. and Kasuga, T.: Heat-labile toxin of Bordetella pertussis purified by preparative acryl-amide gel electrophoresis. Jap. J. Microbiol., 13: 359, 1969.
276. Nakase, Y., Tateishi, M., Sekiya, K. and Kasuga, T.: Chemical and biological properties of the purified O antigen of Bordetella pertussis. Jap. J. Microbiol., 14: 1, 1970.
277. Nakase, Y. and Kasuga, T.: Purified Kagglutinogen of Bordetella pertussis and its properties. Jap. J. Microbiol., 15: 247, 1971.
278. Neimark, F. M., Lugovaya, L. V. and Belova, N. D.: Bordetella parapertussis and its significance in the incidence of pertussis. Zh. Mikrobiol. Epidemiol. Imraunobiol., 32: 49, 1961.
279. Nelson, D. S.: Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts. Transplant. Rev., 19: 226, 1974.
280. Nelson, J. D.: Antibiotic treatment of pertussis. Pediatrics, 44: 474, 1969.
281. Nelson, J. D.: Whooping cough-viral or bacterial disease? N. Engl. J. Med., 283: 428, 1970.
282. Nelson, J. D., Hempstead, B., Tanaka, R. and Pauls, F. P.: Fluorescent antibody diagnosis of infections. J.A.M.A., 188: 1121, 1964.
283. Nelson, J. D., Matteck, B. M. and McNabb, J.: Susceptibility of Bordetella pertussis to ampicillin. J. Pediatr., 68: 222, 1966.
284. Nicholson, D. P.: Pulmonary collapse in pertussis. Arch. Dis. Child., 24: 29, 1949.
285. Niwa, M.: Histamine sensitizing factor of Bordetella pertussis. J. Biochem., 51: 222, 1962.
286. O'Bryan, B. S. and Fishel, Ch. W.: Aggregation of platelets of normal and Bordetella pertussis vaccinated mice by ATP, ADP, and sodium fluoride. Int. Arch. Allergy Appl. Microbiol., 41: 514, 1971.
287. Ochiai, T., Okumura, K., Tada, T. and Iwasa, S.: Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. I. Suppression of cellular hypersensitivity reactions. Int. Arch. Allergy Appl. Microbiol., 43: 196, 1972.
288. Ofek, I., Beachey, E. H. and Bisno, A. L.: Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J. Infect. Dis., 129: 310, 1974.
289. Olson, L. C, Miller, G. and Hanshaw, J. B.: Acute infectious lymphocytosis presenting as a pertussis-like illness: its association with adenovirus type 12. Lancet, 1: 200, 1964.
290. Onoue, K., Kitagawa, M. and Yamamura, Y.: Chemical studies on cellular components of Bordetella pertussis. I. Purification and properties of agglutinogen. J. Bacteriol., 82: 648, 1961.
291. Orlando, R. A., Craft, K., Glick, M. and Wissler, R. W.: Specific enhancement of hepatoma growth using methylated bovine serum albumin and pertussis vaccine. Lab. Invest., 26: 735, 1972.
292. Osborne, J. C: The successful control of hog cholera virus leukopenia with Hemophilus pertussis bacterin. Am. J. Vet. Res., 19: 902, 1958.
293. Pannell, L.: Studies on protection against experimental tularemia in mice. I. Altered susceptibility of white mice to tularemia following Hemophilus pertussis vaccination. J. Infect. Dis., 102: 162, 1958.
294. Parfentjev, I. A.: Bacterial allergy increases susceptibility to influenza virus in mice. Proc. Soc. Exp. Biol. Med., 90: 373, 1955.
295. Parfentjev, I. A., Goodline, M. A. and Virion, M.: A study of sensitivity to Hemophilus perutssis in laboratory animals. J. Bacteriol., 53: 597, 1947.
296. Parker, C. W. and Morse, S. I.: The effect of Bordetella pertussis on lymphocyte cyclic AMP metabolism. J. Exp." Med., 137: 1078, 1973.
297. Pereira, M. S. and Candeias, J.A.N.: The association of viruses with clinical pertussis. J. Hyg. (Camb.), 69: 399, 1971.
298. Phanuphak, P., Moorhead, J. W. and Claman, H. N.: Immunologie activities of pertussis-treated lymphocytes. Int. Arch. Allergy Appl. Microbiol., 43: 305, 1972.
299. Pickett, G.: Symposium on pertussis immunization in honor of Dr. Pearl L. Kendrick in her eightieth year: pertussis control-1970. Health Lab. Sci., 8: 215, 1971.
300. Pieroni, R., Bundeally, A. E. and Levine, L.: Enhancing effect of Bordetella pertussis and propranolol on experimental immune hemolytic anemia. Experientia 27: 332, 1971.
301. Pieroni, R. E., Stevens, D. L., Stojanović, A. and Levine, L.: Investigation of the responsiveness of BCG-vaccinated children with whooping-cough to tuberculin. Int. Arch. Allergy Appl. Immunol., 42: 583, 1972.
302. Pillemer, L.: Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata. Proc. Soc. Exp. Biol. Med., 75: 704, 1950.
303. Pittman, M.: The genus Bordetella MorenoLopez, 1952. Bacteriol. Rev., 19: 273, 1955.
304. Pittman, M.: Effect of Haemophilus pertussis on immunological and physiological reactions. Fed. Proc, 16: 867, 1957.
305. Pittman, M.: Bordetella pertussis-bacterial and host factors in the pathogenesis and prevention of whooping cough. Pages 239-270 in Mudd, S. ed. Infectious Agents and Host Reactions. W. B. Saunders Co., Philadelphia, 1970.
306. Poszgi, N., David, C, Andreescu, V., Caffe, I. and Ghyka, G.: Action of vaccinia virus on the reactivity of albino mice inoculated with pertussis vaccine. Z. Immunitaetsforsch., 142: 129, 1971.
307. Preston, N. W.: Type-specific immunity against whooping-cough. Br. Med. J., 2: 724, 1963.
308. Preston, N. W.: Effectiveness of pertussis vaccines. Br. Med. J., 2: 11, 1965.
309. Preston, N. W.: Potency tests for pertussis vaccines: doubtful value of intracerebral challenge test in mice. J. Path. Bacteriol., 91: 173, 1966.
310. Preston, N. W.: Influence of challenge strain on potency of pertussis vaccines in mice. Nature, 213: 830, 1967.
311. Preston, N. W. and TePunga, W. A.: The relation between agglutinin production by pertussis vaccines and their immunizing potency in mice. J. Pathol. Bacteriol., 78: 209, 1959.
312. Preston, N. W. and Evans, P.: Type-specific immunity against intracerebral pertussis infection in mice. Nature, 197: 508, 1963.
313. Preston, N. W. and Stanbridge, T. S.: Efficacy of pertussis vaccines; a brighter horizon. Br. Med. J., 3: 448, 1972.
314. Proom, H.: The minimal nutritional requirements of organisms of the genus Bordetella López. J. Gen. Microbiol., 12: 63, 1955.
315. Provenzano, R. W., Wetterlow, L. H. and Ipsen, J.: Pertussis immunization in pediatric practice and in public health. N. Engl. J. Med., 261: 473, 1959.
316. Ptak, W., Festenstein, H., Asherson, G. L. and Denman, A. M.: Improved graft survival after treatment with Bordetella and antilym-phocyte serum. Nature, 222: 1063, 1969.
317. Public Health Laboratory Service. Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. Br. Med. J., 4: 329, 1969.
318. Public Health Laboratory Service. Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. Br. Med. J., 1: 259, 1973.
319. Punsalung, A. P., Jr. and Sawyer, W. D.: Role of pili in the virulence of Neisseria gonorrhoeae. Infect. Immun., 8: 255, 1973.
320. Pusztai, Z., Joó, I. and Kiss, I.: Amino-acid metabolism of Bordetella pertussis in liquid cultures. II. Correlation between time of cultivation and amino-acid metabolism. Path. Microbiol. (Basel), 23: 809, 1960.
321. Radbill, S. X.: Whooping cough in fact and fancy. Bull. Hist. Med., 13: 33, 1943.
322. Rai, K. R., Chanana, A. D., Cronkite, E. P., Gulliani, G. L. and Joel, D. D.: Studies on the leukocytopenia due to acute effects of supernatant fluids of Bordetella pertussis cultures. Proc. Soc. Exp. Biol. Med., 136: 433, 1971.
323. Rai, K. R., Chanana, A. D., Cronkite, E. P., Joel, D. D. and Stevens, J. B.: Studies on lymphocytes. XVIII. Mechanism of lymphocytosis induced by supernatant fluids of Bordetella pertussis cultures. Blood, 38: 49, 1971.
324. Raška, K.: The epidemiological surveillance programme. J. Hyg. Epidemiol. Microbiol. Immunol., 8: 137, 1964.
325. Rašková, H. and Vanecek, J.: Pharmacology of bacterial toxins. Pharmacol. Rev., 16: 1, 1964.
326. Reed, C. E.: Pertussis sensitization as an animal model for the abnormal bronchial sensitivity of asthma. Yale J. Biol. Med., 40: 507, 1968.
327. Reed, C. E., Cohen, M. and Enta, T.: Reduced effect of epinephrine on circulating eosinophils in asthma and after beta-adrenergic blockade or Bordetella pertussis vaccine. J. Allergy, 46: 90, 1970.
328. Reed, C. E., Benner, M., Lockey, S. D., Enta, T., Makino, S. and Carr, R. H.: On the mechanism of the adjuvant effect of Bordetella pertussis vaccine. J. Allergy Clin. Immunol., 49: 174, 1972.
329. Regan, J. C. and Tolstoouhov, A.: Relations of acid base equilibrium to the pathogenesis and treatment of whooping cough. N. Y. State J. Med., 36: 1075, 1936.
330. Report, Whooping cough. WHO Health Stat. Rep. 21: 124, 1968.
331. Rich, A. R.: On the etiology and pathogenesis of whooping cough. Bull. Johns Hopkins Hosp. 51: 346, 1932.
332. Richter, G. W. and Kress, Y.: Observations on commensal cultures of Bordetella bronchi-septica and rat hepatoma cells. Electron microscopy. Lab. Invest. 16: 187, 1967.
333. Ross, R., Munoz, J. and Cameron, C: Histamine-sensitizing factor, mouse-protective antigens, and other antigens of some members of the genus Bordetella. J. Bacteriol., 99: 57, 1969.
334. Rowatt, E.: Some factors affecting the growth of Bordetella pertussis. J. Gen. Microbiol., 17: 279, 1957.
335. Rowatt, E.: The growth of Bordetella pertussis: a review. J. Gen. Microbiol., 17: 297, 1957.
336. Sanyal, R. K. and West, G. B.: Anaphylactic shock in the albino rat. J. Physiol., 142: 571, 1958.
337. Sato, Y. and Nagase, K.: Isolation of protective antigen from Bordetella pertussis. Biochem. Biophys. Res. Commun, 27: 195, 1967.
338. Sato, Y. and Arai, H.: Leukocytosis-promoting factor of Bordetella pertussis. Infect. Immun., 6: 899, 1972.
339. Sato, Y., Arai, H. and Suzuki, K.: Leukocytosispromoting factor of Bordetella pertussis. II. Biological properties. Infect. Immun., 7: 992, 1973.
340. Sato, Y., Arai, H. and Suzuki, K.: Leukocytosispromoting factor of Bordetella pertussis. III. Its identity with protective antigen. Infect. Immun., 9: 801, 1974.
341. Schamberg, J. P. and Kolmer, J. A.: Acute Infectious Diseases. Lea and Febiger, Philadelphia, 1928.
342. Shmilovitz, M., Preston, N. W., Zaltser, M. and Cahana, A.: Whooping cough in northern Israel. Isr. J. Med. Sci., 8: 1936, 1972.
343. Schubert, J. H., Eleff, M. G. and Herman, G. J.: Hemagglutination test for pertussis antibody with a soluble extract of Bordetella pertussis. Am. J. Public Health, 51: 441, 1961.
344. Schuchardt, L. F., Munoz, J., Verwey, W. F. and Sagin, J. F.: The relationship of agglutinogen to other antigens of Bordetella pertussis. J. Immunol., 91: 107, 1963.
345. Seki, M. and Sato, Y. The effect of LPF (leukocytosis promoting factor) on the kinetics of colony forming cells. Acta Pathol. Jap., 23: 75, 1973.
346. Sencer, D. J.: Pertussis immunization for medical personnel. Ann. Intern. Med., 76: 1047, 1972.
347. Sher, D. A.: Encephalopathy following pertussis vaccine. Journal-Lancet 72: 249, 1952.
348. Shih Man, C: Pertussis due to Brucella bronchiseptica. Case report. Pediatrics, 6: 227, 1950.
349. Sinkovics, J. G., Shirato, E. and Shullenberger, C. C: Pertussis vaccine as immunological adjuvant in leukemia and lymphoma. Br. Med. J., 1: 565, 1970.
350. Smith, C. H.: Acute infectious lymphocytosis. Adv. Pediatr., 2: 64, 1947.
351. Smith, C. H.: Blood Diseases of Infancy and Childhood, 2nd edition. C. V. Mosby, St. Louis, 1966, pp. 482-488.
352. Smith, M. H.: Immunization; the current scene. Hosp. Pract., 4: 42, 1969.
353. Stainer, D. W. and Scholte, M. J.: A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol., 63: 211, 1971.
354. Stanbridge, T. N. and Preston, N. W.: Experimental pertusis infection in the vaccinated and unvaccinated marmoset: similarities to natural infection in the child. J. Clin. Pathol., 25: 551, 1972.
355. Standfast, A. F. B.: Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route. Immunology, 1: 123, 1958.
356. Standfast, A. F. B.: Pertussis, typhoid-paratyphoid and cholera vaccines. Br. Med. Bull., 25: 189, 1969.
357. Stevenet, P.: Pertussis and respiratory allergies in infants. Advantage of pertussis vaccine (in French). Rev. Hyg. Med. Sociale, 9:147, 1961.
358. Sticker, G. Whooping cough. Pages 539-620 in Moore, J. W., ed. Variola, Vaccination, Varicella, Cholera, Erysipelas, Whooping Cough, Hay Fever. W. B. Saunders Co., Philadelphia, 1906.
359. Strangert, K.: Comparison between the effect of chloramphenicol and ampicillin in whooping-cough. Scand. J. Infect. Dis., 1: 67, 1969.
360. Strangert, K.: Clinical course and prognosis of whooping-cough in Swedish children during the first six months of life. Scand. J. Infect. Dis., 2: 45, 1970.
361. Strižová, V. and Trilfajová, J.: The neutralization of B. pertussis toxin in a tissue culture. J. Hyg. Epidemiol. Microbiol. Immunol., 8: 428, 1964.
362. Ström, J.: Is universal vaccination against pertussis always justified? Br. Med. J., 2: 1184, 1960.
363. Ström, J.: Social development and declining incidence of some common epidemic diseases in children. A study of the incidence in different age groups in Stockholm. Acta Paediatr. Scand., 56: 159, 1967.
364. Ström, J.: Further experiences of reactions, especially of a cerebral nature, in connection with triple vaccination: a study based on vaccinations in Sweden 1959-1965. Br. Med. J., 4: 320, 1967.
365. Sturdy, P. M., Court, S. D. M. and Gardner, P. S.: Viruses and whooping-cough. Lancet, 2: 978, 1971.
366. Sutcliffe, E. M. and Abbott, J. D.: Selective medium for the isolation of Bordetella pertussis and parapertussis. J. Clin. Pathol., 25: 732, 1972.
367. Sutherland, I. W.: The protective activity of components of Bordetella pertussis cell walls. Immunology, 6: 246, 1963.
368. Sutherland, I. W. and Wilkinson, J. F.: A new growth medium for virulent Bordetella pertussis. J. Pathol. Bacteriol., 82: 431, 1961.
369. Swanson, J.: Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med., 137: 571, 1973.
370. Switzer, W. P., Mare, C. J. and Hubbard, E. D.: Incidence of Bordetella bronchiseptica in wild life and man in Iowa. Am. J. Vet. Res., 27: 1134, 1966.
371. Tabachnik, I. I. A. and Gulbenkian, A.: Adrenergic changes due to pertussis: insulin, glucose and free fatty acids. Eur. J. Pharmacol., 7: 186, 1969.
372. Tada, T., Okumura, K., Ochiai, T. and Iwasa, S.: Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. II. Adjuvant effect for the production of rea-ginic antibody in the rat. Int. Arch. Allergy Appl. Microbiol., 43: 207, 1972.
373. Takeda, K.: Agglutination of bacteria (Haemophilus pertussis and Salmonella typhosa) in vitro by human blood lymphocytes and cytoplasmic extrusions of lymphocytes. J. Infect Dis., 94: 72, 1954.
374. Taub, R. N. and Gershon, R. K.: The effect of localized injection of adjuvant material on the draining lymph node. III. Thymus dependence. J. Immunol., 108: 377, 1972.
375. Taub, R. N., Rosett, W., Adler, A. and Morse, S. I.: Distribution of labelled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J. Exp. Med., 136: 1581, 1972.
376. Thompson, G. E.: Experimental acute pulmonary edema in the rat. Effect of Bordetella pertussis vaccine on ozone mortality. Arch. Environ. Health, 23: 154, 1971.
377. Tjabbes, T. and de Weid, D.: The influence of the ventral posterior hypothalamus on Bordetella pertussis vaccine-induced eosinophilia. Arch. Int. Pharmacodyn. Ther., 135: 218, 1962.
378. Twarog, F. J. and Rose, N. R.: The adjuvant effect of pertussis vaccine in experimental thyroiditis of the rat. Proc. Soc. Exp. Biol. Med., 130: 434, 1969.
379. Ungar, J.: Pertussis immunization. Br. J. Clin. Pract., 17: 673, 1963.
380. Ungar, J., Muggleton, P. W. and Stevens, W. K.: The type specificity of Haemophilus pertussis. J. Hyg. (Camb.), 52: 475, 1954.
381. Urquhart, G. E. D., Moffat, M. A. J., Calder, M. A. and Cruickshank, G. M.: An aetiological study of respiratory infection in children, Edinburgh City Hospital, 1961-1963. J. Hyg. (Camb.), 63: 187, 1965.
382. Voino-Yasenetsky, M. V. and Khai, L. M.: Development of the infectious process in relation to conditions of inoculation. J. Hyg. Epidemiol. Microbiol. Immunol., 4: 405, 1960.
383. Vysoká, B.: The epidemiology of pertussis and parapertussis. J. Hyg. Epidemiol. Microbiol. Immunol., 2: 196, 1958.
384. Vysoká-Burianova, B.: Contemporary problems in the epidemiology of whooping cough. J. Hyg. Epidemiol. Microbiol. Immunol., 7: 472, 1963.
385. Walker, S. W.: Cardiac complications of pertussis. J. Pediatr., 40: 200, 1952.
386. Ward, M. E., Watt, P. J. and Robertson, J. N.: The human fallopian tube: a laboratory model for gonococcal infection. J. Infect. Dis., 129: 650, 1974.
387. Wardlaw, A. C. and Jakus, C. M.: Intracerebral mouse protection test for pertussis vaccine. I. Apparent absence of humoral protective antibody under the usual test conditions. Can. J. Microbiol., 14: 989, 1968.
388. Washburn, T. C, Medearis, D. N. and Childs, B.: Sex differences in susceptibility to infections. Pediatrics, 35: 57, 1965.
389. Wasz-Höckert, O. and Backman, A.: Studies on the host-parasite relationship. II. Influence of pertussis vaccine on guinea-pig tuberculosis. Ann. Med. Exp. Biol. Fenn. 34: 277, 1956.
390. Watts, C. C. and Acosta, C: Pertussis and bilateral subdural hematomas. Am. J. Dis. Child., 118: 518, 1969.
391. Wehrle, P. F. Current immunization methods and precautions. Calif. Med., 101: 153, 1964.
392. Weinstein, L.: Infectious disease: retrospect and reminiscence. J. Infect. Dis., 129: 480, 1974.
393. Welsh, J. D., Denny, W. F. and Bird, R. M.: The incidence and significance of the leukemoid reaction in patients hospitalized with pertussis. South. Med. J., 52: 643, 1959.
394. Whitaker, J. A., Donaldson, P. and Nelson, J. D.: Diagnosis of pertussis by the fluorescent-antibody method. N. Engl. J. Med., 263: 850, 1960.
395. White, R., Finberg, L. and Tramer, A.: The modern morbidity of pertussis in infants. Pediatrics, 33: 705, 1964.
396. Wilkins, J., Williams, F. F., Wehrle, P. F. and Portnoy, B.: Agglutinin response to pertussis vaccine. I. Effect of dosage and interval. J. Pediatr., 79: 197, 1971.
397. Williams, A. W.: The etiology of pertussis. Arch. Pediatr., 31: 567, 1914.
398. Williams, R. C. and Gibbons, R. J.: Inhibition of bacterial adherence by secretory immunoglob-ulin A: a mechanism of antigen disposal. Science, 177: 697, 1972.
399. Williams, S.: The value of broad-spectrum antibiotics in the treatment of pertussis. Antibiotics Annual, 1956-1957, pp. 316-318.
400. Willoughby, D. A.: The mechanism of cutaneous hypersensitivity in the rat and its suppression by immunological methods. J. Pathol. Bacteriol., 92: 139, 1966.
401. Wilson, A. T., Henderson, I. R., Moore, E. J. H. and Heywood, S. N.: Whooping cough: difficulties in diagnosis and ineffectiveness of immunization. Br. Med. J., 1: 623, 1965.
402. Wilson, G. S.: The Hazards of Immunization. The Athlone Press, London, 1967.
403. Wilson, J. Neurological complications of DPT inoculation in infancy. Arch. Dis. Child., 48: 829, 1973.
404. Wilson, R. J.: Cultivation of Bordetella pertussis (Phase I) in a chemically defined medium. Can. J. Public Health, 54: 518, 1963.
405. Wolman, L.: Cerebral damage in whoopingcough. Br. Med. J., 2: 775, 1962.
406. Woolf, A. L. and Caplin, H.: Whooping cough encephalitis. Arch. Dis. Child., 31: 87, 1956.
407. World Health Organization. Whooping cough. Weekly Epidemiol. Record, 46: 169, 1971.
408. Zellweger, H.: Pertussis encephalopathy. Arch. Pediatr., 76: 381, 1959.
409. Zoumboulakis, D., Anagnostakis, D., Albanis, V. and Matsaniotis, N.: Steroids in treatment of pertussis. A controlled clinical trial. Arch. Dis. Child., 48: 51, 1973.
410. Zuelzer, W. W. and Wheeler, W. E.: Parapertussis pneumonia. Report of two fatal cases. J. Pediatr., 29: 493, 1946.